Tissue-Specific Progenitor and Stem Cells Human Cartilage-Derived Progenitor Cells From Committed Chondrocytes for Efficient Cartilage Repair and Regeneration
Tissue-Specific Progenitor and Stem Cells Human Cartilage-Derived Progenitor Cells From Committed Chondrocytes for Efficient Cartilage Repair and Regeneration
复制标题
DOI:
--
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Yangzi Jiang;Youzhi Cai;Wei Zhang-;Zi Yin;Changchang Hu;Tong Tong-Tong;Ping Lu;Shufang Zhang;D. Neculai;R. Tuan;H. Ouyang
中科院分区:
文献类型:
--
作者:
Yangzi Jiang;Youzhi Cai;Wei Zhang-;Zi Yin;Changchang Hu;Tong Tong-Tong;Ping Lu;Shufang Zhang;D. Neculai;R. Tuan;H. Ouyang
Articular cartilage is not a physiologically self-renewing tissue. Injury of cartilage often progresses from the articular surface to the subchondral bone, leading to pathogenesis of tissue degenerative diseases, such as osteoarthritis. Therapies to treat cartilage defects using autologous chondrocytebased tissue engineering have been developed and used for more than 20 years; however, the challenge of chondrocyte expansion in vitro remains. A promising cell source, cartilage stem/progenitor cells (CSPCs), has attracted recent attention. Because their origin and identity are still unclear, the application potential of CSPCs is under active investigation. Here we have captured the emergence of a group of stem/progenitor cells derived from adult human chondrocytes, highlighted by dynamic changes in expression of themature chondrocytemarker, COL2, andmesenchymal stromal/stem cell (MSC)marker, CD146. These cells are termed chondrocyte-derived progenitor cells (CDPCs). The stem cell-like potency and differentiation status of CDPCs were determined by physical and biochemical cues during culture. A low-density, low-glucose 2-dimensional culture condition (2DLL) was critical for the emergence and proliferation enhancement of CDPCs. CDPCs showed similar phenotype as bone marrowmesenchymal stromal/stem cells but exhibited greater chondrogenic potential. Moreover, the 2DLL-cultured CDPCs proved efficient in cartilage formation both in vitro and in vivo and in repairing large knee cartilage defects (6–13 cm) in 15 patients. These findings suggest a phenotype conversion between chondrocytes and CDPCs and provide conditions that promote the conversion. These insights expand our understanding of cartilage biology and may enhance the success of chondrocyte-based therapies. STEM CELLS TRANSLATIONAL MEDICINE 2016;5:733–744